Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Minerva Stomatol ; 63(7-8): 267-72, 2014.
Article in English | MEDLINE | ID: mdl-25299361

ABSTRACT

AIM: Even after a complete root canal therapy, reinfection may occur as a result of incomplete seal and activation of residual bacteria. Thus, antimicrobial activity is an important characteristic of root canal sealers. MTA Fillapex is a newly developed MTA-based sealer. It has been subjected to various studies evaluating its physical and chemical properties. In this study, we aimed to compare the antimicrobial activity of this sealer to the commonly known widely accepted sealer, AH26. METHODS: MTA Fillapex and AH 26 were exposed the bacterial suspension of Enterococcus faecalis, Escherichia coli, Streptococcus mutans, and Candida albicans after setting. After incubation and complete evaporation, BHI was added to microtubes. 24 hours later, the liquid content was placed in agar diffusion plate and bacterial count was performed. ANOVA followed by Tukey test, and t-Test were performed to analyze the data. RESULTS: With regard to all four bacterial groups, the bacterial count was significantly lower in MTAFillapex group comparing to AH 26 group. CONCLUSION: Newly developed MTA Fillapex sealer, has better antimicrobial properties in comparison to the widely accepted AH26 sealer.


Subject(s)
Aluminum Compounds/pharmacology , Anti-Infective Agents/pharmacology , Bismuth/pharmacology , Calcium Compounds/pharmacology , Candida albicans/drug effects , Enterococcus faecalis/drug effects , Epoxy Resins/pharmacology , Escherichia coli/drug effects , Oxides/pharmacology , Root Canal Filling Materials/pharmacology , Silicates/pharmacology , Silver/pharmacology , Streptococcus mutans/drug effects , Titanium/pharmacology , Colony Count, Microbial , Drug Combinations , Drug Evaluation, Preclinical , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...